Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by cAMP in HepG2 liver cells

Journal of Biochemistry

Volumn 150, Issue 6, 2011, Pages 687-694

  Asakura, Takefumi ^a   Iwaki, Soichiro ^a   Okada, Hiromi ^a   Sobel, Burton E ^b   Fujii, Satoshi ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

3 untranslated region; cAMP; mRNA stability; PAI 1; posttranscriptional regulation

Indexed keywords

CYCLIC AMP; LUCIFERASE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

3' UNTRANSLATED REGION; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

3' UNTRANSLATED REGIONS; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; CULTURE MEDIA; HEP G2 CELLS; HUMANS; LIVER; LUCIFERASES; NUCLEIC ACID CONFORMATION; PLASMIDS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

EID: 82955201655     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvr110     Document Type: Article

References (32)

1. Alessi, M.C. and Juhan, J.I. (2008) Metabolic syndrome, haemostasis and thrombosis. Thromb. Haemost. 99, 995-1000
2. Hamsten, A., Wiman, B., de, Faire, U., and Blomback, M. (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med. 313, 1557-1563 (Pubitemid 16177394)
3. Schneider, D.J., Hayes, M., Wadsworth, M., Taatjes, H., Rincon, M., Taatjes, D.J., and Sobel, B.E. (2004) Attenuation of neointimal vascular smooth muscle cellu-larity in atheroma by plasminogen activator inhibitor type-1 (PAI-1). J. Histochem. Cytochem. 52, 1091-1099 (Pubitemid 38982198)
4. Vulin, A.J. and Stanley, F.M. (2004) Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J. Biol. Chem. 279, 25172-25178 (Pubitemid 38756767)
5. Tawfik, H.E., El-Remessy, A.B., Matragoon, S., Ma, G., Caldwell, R.B., and Caldwell, R.W. (2006) Simvastatin improves diabetes-induced coronary endothelial dysfunction. J. Pharmacol. Exp. Ther. 319, 386-395 (Pubitemid 44455146)
6. Sato, Y., Dong, J., Imagawa, S., Ishimori, N., Furumoto, T., Tsutsui, H., Sobel, B.E., and Fujii, S. (2008) Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1. Coron. Artery. Dis. 19, 355-361
7. Ma, Z., Kwong, K.Y., Tovar, J.P., and Peak, D. (2010) Cyclic adenosine monophosphate induces plasminogen activator inhibitor-1 expression in human mast cells. Biochem. Biophys. Res. Commun. 400, 569-574
8. Schiller, M., Verrecchia, F., and Mauviel, A. (2003) Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism. Oncogene 22, 8881-8890 (Pubitemid 38021504)
9. Mohamed, R.H. (2009) Role of cilostazol in alleviating cardiovascular complications induced in experimental rats through regulation of type 1 plasminogen activator inhibitor and transforming growth factor-p1 over-expression. Biomed. Pharmacother, doi.10.1016./j.biopha.2009.02.005
10. Lee, K.M., Lee, H.J., Kim, M.K., Kim, H.S., Jung, G.S., Hur, S.H., Kim, H.T., Cho, W.H., Kim, J.G., Kim, B.W., Kim, J.O., Choi, H.S., Lee, K.U., Park, K.G., and Lee, I.K. (2009) Cilostazol inhibits high glucose-and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury. Atherosclerosis 207, 391-398
11. Ota, H., Eto, M., Kano, M.R., Ogawa, S., Iijima, K, Akishita, M., and Ouchi, Y. (2008) Cilostazol inhibits oxidative stress-induced premature senescence via upre-gulation of Sirt1 in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 1634-1639
12. Uno, S., Nakamura, M., Seki, T., and Ariga, T. (1997) Induction of tissue-type plasminogen activator (tPA) and type-1 plasminogen activator inhibitor (PAI-1) as early growth responses in rat hepatocytes in primary culture. Biochem. Biophys. Res. Commun. 239, 123-128 (Pubitemid 27480327)
13. Heaton, J.H. and Gelehrter, T.D. (1990) Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells. Mol. Endocrinol. 4, 171-178
14. Uno, S., Nakamura, M., Ohomagari, Y., Matsuyama, S., Seki, T., and Ariga, T. (1998) Regulation of tissue-type plasminogen activator (tPA) and type-1 plasminogen activator inhibitor (PAI-1) gene expression in rat hepatocytes in primary culture. J. Biochem. 123, 806-812 (Pubitemid 28226973)
15. Heaton, J.H., Dlakic, W.M., and Gelehrter, T.D. (2003) Posttranscriptional regulation of PAI-1 gene expression. Thromb. Haemost. 89, 959-966 (Pubitemid 36798146)
16. Dong, J., Fujii, S., Imagawa, S., Matsumoto, S., Matsushita, M., Todo, S., Tsutsui, H., and Sobel, B.E. (2007) Interleukin (IL)-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBP8. Am. J. Physiol. Cell physiol. 292, C209-C215 (Pubitemid 46115131)
17. Imagawa, S., Fujii, S., Dong, J., Furumoto, T., Kaneko, T., Zaman, T., Satoh, Y., Tsutsui, H., and Sobel, B.E. (2006) Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells. Arterioscler. Thromb. Vasc. Biol. 26, 2407-2413 (Pubitemid 44465741)
18. Rabani, M., Kertesz, M., and Segal, E. (2008) Computational prediction of RNA structural motifs involved in posttranscriptional regulatory processes. Proc. Natl. Acad. Sci. USA. 105, 14885-14890
19. Fattal, P.G. and Billadello, J.J. (1993) Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA. Nucleic Acids Res. 21, 1463-1466 (Pubitemid 23154379)
20. Fattal, P.G., Schneider, D.J., Sobel, B.E., and Billadello, J.J. (1992) Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1. J. Biol. Chem. 267, 12412-12415
21. Westerhausen, D.R. Jr., Hopkins, W.E., and Billadello, J.J. (1991) Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells. J. Biol. Chem. 266, 1092-1100 (Pubitemid 21907230)
22. Misquitta, CM., Iyer, V.R., Werstiuk, E.S., and Grover, A.K. (2001) The role of 3'-untranslated region mediated mRNA stability in cardiovascular pathophysiology. Mol. Cell. Biochem. 224, 53-67 (Pubitemid 32962652)
23. Keene, J.D. (2007) RNA regulons: coordination of post-transcriptional events. Nat. Rev. Genet. 8, 533-543 (Pubitemid 46955210)
24. Bakheet, T., Frevel, M., Williams, B.R., Greer, W., and Khabar, K.S. (2001) ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res. 29, 246-254 (Pubitemid 32054460)
25. Doller, A., Gauer, S., Sobkowiak, E., Geiger, H, Pfeilschifter, J., and Eberhardt, W. (2009) Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor Human-Antigen R. Am. J. Pathol. 174, 1252-1263
26. Shetty, S., Shetty, P., Idell, S., Velusamy, T., Bhandary, V.P., and Shetty, R.S. (2008) Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53. J. Biol. Chem. 283, 19570-19580
27. Shetty, S., Velusamy, T., Shetty, R.S., Marudamuthu, A.S., Shetty, S.K., Florova, G., Tucker, T., Koenig, K., Shetty, P., Bhandary, Y.P., and Idell, S. (2010) Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 43, 358-367
28. Watanabe, S., Takeshige, K., and Muta, T. (2007) A cis-element in the 3'-untranslated region of IxB-zeta mRNA governs its stimulus-specific expression. Biochem. Biophys. Res. Commun. 356, 785-791 (Pubitemid 46499035)
29. Dimova, E.Y., Jakubowska, M.M., and Kietzmann, T. (2007) CREB binding to the hypoxia-inducible factor-1 responsive elements in the plasminogen activator inhibitor-1 promoter mediates the glucagon effect. Thromb. Haemost. 98, 296-303 (Pubitemid 47250231)
30. Klemm, D.J., Roesler, W.J., Boras, T., Colton, L.A., Felder, K., and Reusch, J.E. (1998) Insulin stimulates cAMP-response element binding protein activity in HepG2 and 3T3-L1 cell lines. J. Biol. Chem. 273, 917-923 (Pubitemid 28049185)
31. Hentze, M.W. and Kuhn, L.C. (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. USA 93, 8175-8182 (Pubitemid 26269529)
32. Sobel, B.E., Taatjes, D.J., and Schneider, D.J. (2003) Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 1979-1989 (Pubitemid 37433189)